Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028

1
Prostate Cancer Nuclear Medicine Diagnostics
Market Global Analysis and Forecast to 2028

• Published Date May 2022

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com

• Prostate Cancer Nuclear Medicine Diagnostics
  Market Forecast to 2028 - COVID-19 Impact and
  Global Analysis By Type (PET and SPECT), PET
  Product (F-18, C-11, and Ga68-PSMA), and End User
  (Hospitals, Clinics, and Others)

3
Prostate Cancer Nuclear Medicine Diagnostics
Market Overview
Email sales_at_theinsightpartners.com

• The Prostate Cancer Nuclear Medicine Diagnostics
  Market is expected to grow from US 720.12
  million in 2022 to US 1,315.66 million by 2028.
  It is estimated to grow at a CAGR of 10.6 from
  2022 to 2028.
• Prostate cancer affects the prostate glands in
  males. Prostate cancer is common cancer following
  skin cancer in males. Some common determinants
  responsible for the start of prostate cancer are
  family history, old age, and race. Nuclear
  medicine is imaging that needs radioactive
  materials. It is a helpful method to identify and
  treat prostate cancer and helps radiologists
  conclude the stage of cancer.

4
Key Segment Market
Email sales_at_theinsightpartners.com

• Segment By Type-
• By Type (PET and SPECT)
• PET Product (F-18, C-11, and Ga68-PSMA)
• End User (Hospitals, Clinics, and Others)

Download Sample Here
5
Prostate Cancer Nuclear Medicine Diagnostics
Market Value
Email sales_at_theinsightpartners.com

• CAGR of 10.6 (2022-2028)

6
Company Profiles
Email sales_at_theinsightpartners.com

• Blue Earth Diagnostics Limited
• ImaginAB
• Curium
• Jubilant Radiopharma
• NCM-USA LLC
• ABX Advanced Biochemical Compounds GmbH
• Telix Pharmaceuticals Ltd.
• Novartis AG
• Theragonostics
• Lantheus Medical Imaging Inc

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com

• North America (the US, Canada, and Mexico)
• Europe (the UK, Germany, France, Italy, Spain,
  and the Rest of Europe)
• Asia Pacific (China, Japan, India, Australia,
  South Korea, and the Rest of Asia Pacific)
• Middle East Africa (the UAE, Saudi Arabia,
  South Africa, and the Rest of Middle East
  Africa)
• South Central America (Brazil, Argentina, and
  the Rest of South Central America).

8
THANKYOU!

• Phone  [phone]

• E-Mail sales_at_theinsightpartners.com